Form: 10-Q

Quarterly report [Sections 13 or 15(d)]

November 16, 2026


Exhibit 10.4

EXCHANGE AGREEMENT
EXCHANGE AGREEMENT, dated as of November 13, 2026 (this “Agreement”), by and between Veritone, Inc., a Delaware corporation (the “Company”), and the undersigned investor (the “Investor”), on its own behalf and on behalf of each of the beneficial owners listed on Annex I hereto (each, an “Account”) for whom the Investor holds contractual and investment authority (each Account, including the Investor if it is exchanging Existing Notes in the Exchange (each, as defined below) on its own behalf, an “Exchanging Investor”). If there is only one Account or Exchanging Investor, then each reference thereto in this Agreement will be deemed to refer to such Account or Exchanging Investor, as applicable, in the singular, mutatis mutandis.
WHEREAS, the Company and each Exchanging Investor desire to engage in the Exchange (as defined below) on the terms set forth in this Agreement.
THEREFORE, the Company and the Investor (on behalf of itself and each Exchanging Investor) agree as follows.
Section 1.DEFINITIONS. Capitalized terms in this Agreement shall have the meanings specified below, or as specified elsewhere in this Agreement, for all purposes hereof. The following terms, as used in this Agreement, shall have the meanings as set forth below:
“Business Day” means any day other than a Saturday, a Sunday or any day on which the Federal Reserve Bank of New York is authorized or required by law or executive order to close or be closed.
“Code” means the U.S. Internal Revenue Code of 1986, as amended.
“Common Stock” means the common stock, $0.001 par value per share, of the Company.
“DTC” means The Depository Trust Company.
“DWAC” means DTC’s Deposit / Withdrawal at Custodian program.
“Exchange Act” means the Securities Exchange Act of 1934, as amended.
“Exchange Consideration” means, with respect to the Existing Notes of any Exchanging Investor to be exchanged in the Exchange, (a) cash in an amount equal to accrued and unpaid interest on such Existing Notes from, and including, May 15, 2026 to, but excluding, November 15, 2026, calculated in accordance with the Existing Indenture (the “Accrued Interest Payment”), (b) the New Notes, which New Notes have an aggregate principal amount equal to 100% of the principal amount of such Existing Notes, and (c) a number of Exchange Shares (rounded to the nearest whole number of shares) equal to 2.0% of the aggregate principal amount of Existing Notes divided by $0.4906. The number of Exchange Shares comprising part of the



Exchange Consideration shall be adjusted in good faith by the Company for any stock dividend, stock split, stock combination, reclassification or similar transaction occurring on or after the date hereof and prior to or on the Closing Date.
“Exchange Shares” means the shares of Common Stock issuable pursuant to this Agreement as part of the Exchange Consideration with respect to any of the Exchanging Investors.
“Existing Indenture” means that certain Indenture, dated as of November 19, 2021, between the Company and the Existing Notes Trustee.
“Existing Notes” means the Company’s 1.75% Convertible Senior Notes due 2026 issued pursuant to the Existing Indenture.
“Existing Notes Trustee” means U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), in its capacity as trustee under the Existing Indenture.
“General Disclosure Package” means each of the following documents: (a) the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed with the SEC on April 15, 2026; (b) the Company’s Amendment No. 1 to Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed with the SEC on April 29, 2026; (c) the Company’s Quarterly Reports on Form 10-Q for the fiscal quarter ended March 31, 2026 filed with the SEC on May 14, 2026 and the fiscal quarter ended June 30, 2026 filed with the SEC on August 13, 2026, (d) the Company’s draft financial statements for the quarter ended September 30, 2026 (the “Draft Earnings Release”), and (e) the Company’s Current Reports on Form 8-K (excluding any Current Reports or portions thereof that are furnished, and not filed, pursuant to Item 2.02 or Item 7.01 of Form 8-K, and any related exhibits) filed with the SEC on or after January 1, 2026.
“IRS” means the U.S. Internal Revenue Service.
“Liens” means any mortgages, liens, pledges, charges, security interests, encumbrances, title retention agreements, options, preemptive rights, equity or other adverse claims.
“Nasdaq” means The Nasdaq Stock Market LLC.
“New Notes” means the Company’s 1.75% Convertible Senior Notes due December 15, 2026.
“New Notes Indenture” means an Indenture, to be dated as of the Closing Date, by and between the Company, the Subsidiary Guarantors, and the New Notes Trustee, which Indenture is substantially in the form set forth as Exhibit D hereto.
“New Notes Trustee” means U.S. Bank Trust Company, National Association, in its capacity as trustee under the New Notes Indenture.
- 2 -


“New Securities” means the New Notes, the Subsidiary Guarantees and the Exchange Shares.
“Other Investors” means the other investors that have entered into exchange agreements for Exchange Consideration on substantially the same terms as those of this Agreement.
“SEC” means the U.S. Securities and Exchange Commission.
“Securities Act” means the Securities Act of 1933, as amended.
“Subsidiary Guarantees” means the guarantees of the obligations of the Company provided by the Subsidiary Guarantors pursuant to the New Notes Indenture.
“Subsidiary Guarantors” means Broadbean, Inc., Broadbean Talent Solutions, Inc., Table Rock Management LLC, Veritone Digital, Inc. and Veritone Enterprise, LLC.
“Transfer Agent” means Computershare Trust Company, N.A., in its capacity as the transfer agent of the Company.
Section 2.RULES OF CONSTRUCTION. For purposes of this Agreement: (a) “or” is not exclusive; (b) “including” means “including without limitation”; (c) “will” expresses a command; (d) words in the singular include the plural and in the plural include the singular, unless the context requires otherwise; (e) “herein,” “hereof” and other words of similar import refer to this Agreement as a whole and not to any particular Section or other subdivision of this Agreement, unless the context requires otherwise; (f) references to currency mean the lawful currency of the United States of America, unless the context requires otherwise; (g) the annexes, exhibits, schedules and other attachments to this Agreement are deemed to form part of and to be included in this Agreement; (h) references to documents and agreements are deemed to be to such documents and agreements as amended, restated, supplemented or modified from time to time; and (i) references to any statute or regulation shall include any amendments or supplements of the same and any successor statutes and regulations, together with all rules and regulations promulgated thereunder.
Section 3.THE EXCHANGE.
(a)Generally. Subject to the other terms of this Agreement, the Investor agrees to cause each Exchanging Investor to exchange with the Company the aggregate principal amount of the Existing Notes set forth in Annex I hereto that such Exchanging Investor beneficially owns for the Exchange Consideration in kind and amount as set forth in Annex I hereto (the “Exchange”).
(b)The Closing.
(i)Closing Date and Location. The closing of the Exchange (the “Closing”) will take place at the offices of Cooley LLP, 350 S. Grand Avenue, Suite 3200, Los Angeles, CA 90071 at 10:00 a.m., New York City time, on the later of (1) November 13, 2026; (2) such date on which the conditions to Closing set forth in Section 6 are satisfied or waived (other than those conditions that by their terms are to be satisfied at the Closing, but subject to the satisfaction or waiver thereof at the Closing); and (3) such other time and place as the Company and the Investor may agree (such later date, the “Closing Date”).
(ii)Conveyance of Title; Release of Claims. Subject to the other terms and conditions of this Agreement, concurrently with the Closing, the Investor hereby, for itself and on behalf of each Exchanging Investor, sells, assigns and transfers to, or upon
- 3 -


the order of, the Company, all right, title and interest in such portion of the Existing Notes as indicated on Annex I hereto, waives any and all other rights with respect to such Existing Notes and the Existing Indenture and releases and discharges the Company from any and all claims, whether now known or unknown, the Investor and any other Exchanging Investor may now have, or may have in the future, arising out of, or related to, such Existing Notes, including any claims arising from any existing or past defaults under the Existing Indenture, or any claims that the Investor or any Exchanging Investor is entitled to receive additional, special or default interest with respect to the Existing Notes, but excluding any claims by the Investor or any Exchanging Investor pursuant to this Agreement, the New Securities or the New Notes Indenture.
(iii)Delivery of Existing Notes and Exchange Consideration.
(1)DWAC Withdrawal. Subject to satisfaction or waiver of the applicable conditions precedent specified in this Agreement, at or prior to 9:30 a.m., New York City time, on the Closing Date, the Investor agrees to direct one or more eligible DTC participants through which each Exchanging Investor holds a beneficial interest in the Existing Notes to submit one or more DWAC withdrawal instructions (the “DWAC Withdrawal”) to the Existing Notes Trustee for the aggregate principal amount of the Existing Notes to be exchanged by such Exchanging Investor pursuant to this Agreement, or comply with such other settlement procedures mutually agreed in writing by the Investor and the Company.
(2)DWAC Deposits. DTC will act as securities depositary for the New Securities. Subject to satisfaction or waiver of the applicable conditions precedent specified in this Agreement, at or prior to 9:30 a.m. New York City time on the Closing Date, the Investor agrees to direct one or more eligible DTC participants to submit, separately for each Exchanging Investor, one or more DWAC deposit instructions (the “DWAC Deposits”) to the New Notes Trustee for the aggregate principal amount of the New Notes, and to the Transfer Agent for the aggregate number of Exchange Shares, in each case that such Exchanging Investor is entitled to receive pursuant to this Agreement, or comply with such other settlement procedures mutually agreed in writing by the Investor and the Company.
(3)Delivery of Exchange Consideration. If the Closing does not occur, then any Existing Notes submitted for DWAC Withdrawal will be promptly returned to the DTC participant that submitted the DWAC Withdrawal instruction in accordance with the procedures of DTC. On the Closing Date, subject to satisfaction or waiver of the conditions precedent specified in this Agreement, and, if applicable, the prior receipt of one or more valid DWAC Deposits conforming with the aggregate principal amount of the New Notes and the aggregate number of Exchange Shares to be issued to such Exchanging Investor in the Exchange, the Company will (A) execute the New Notes, and direct the New Notes Trustee to authenticate such New Notes, (B) by acceptance of the DWAC Deposits (or by such other settlement procedures as mutually agreed in writing by the Investor and the Company), deliver the New Securities to the DTC accounts specified on Exhibit A to this Agreement and (C) pay the Accrued Interest Payment in immediately available funds by wire transfer to each Exchanging Investor in accordance with the wire instructions provided specified on Exhibit A to this Agreement. Existing Notes delivered for exchange shall not be cancelled until the applicable Exchanging Investor has received all of its Exchange Consideration.
- 4 -


(4)Acknowledgment of DWAC Posting Expiration; Delivery Instructions. The Investor acknowledges that each of the DWAC Withdrawal and the DWAC Deposits must be posted on the Closing Date and that if it is posted before the Closing Date, then it will expire unaccepted and must be resubmitted on the Closing Date. For the convenience of each Exchanging Investor, attached hereto as Exhibit B is a summary of the delivery instructions that must be followed to settle the Exchange through DTC.
(5)Other Exchanges. The Investor acknowledges that Other Investors are participating in similar exchanges, each of which contemplates a DWAC Withdrawal and DWAC Deposits. The Company intends to complete the DWAC Deposits concurrently for all Exchanging Investors and the Other Investors. In particular, unless otherwise agreed by the Investor in writing, the Company will not instruct the Existing Notes Trustee, New Notes Trustee or the Transfer Agent to accept any DWAC Withdrawal or DWAC Deposits unless and until all DWAC withdrawals and deposits for all Other Investors under their appliable exchange agreements (i) are located by the Existing Notes Trustee, New Notes Trustee or the Transfer Agent, as applicable, (ii) conform to the terms of the appliable exchange agreement executed by the applicable Other Investor and (iii) are concurrently accepted by the Existing Notes Trustee, New Notes Trustee or the Transfer Agent, as applicable.
(6)Delay of Closing. If (A) the Existing Notes Trustee is unable to locate the DWAC Withdrawal, (B) the New Notes Trustee or the Transfer Agent is unable to locate the DWAC Deposits, (C) such DWAC Withdrawal does not conform to the Existing Notes to be exchanged in the Exchange or (D) such DWAC Deposits do not conform to the New Notes or Exchange Shares to be issued in the Exchange, then the Company will promptly notify the Investor. If, because of the occurrence of an event described in clause (A), (B), (C) or (D) of the preceding sentence, the New Securities are not delivered on the Closing Date, then such New Securities will be delivered on the first Business Day following the Closing Date (or as soon as reasonably practicable thereafter) on which all applicable conditions set forth in clauses (A), (B), (C) and (D) of the first sentence of this paragraph have been cured.
(c)Consummation of Closing. Subject to the other terms of this Agreement, all acts, deliveries and confirmations comprising the Closing, regardless of chronological sequence, will be deemed to occur contemporaneously and simultaneously on the Closing Date.
Section 4.REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE COMPANY . The Company represents and warrants, as of the date hereof and as of the Closing Date, to the Exchanging Investors and covenants with the Exchanging Investors that:
(a)Due Formation, Valid Existence and Good Standing; Power to Perform Obligations. The Company is duly formed, validly existing and in good standing under the laws of the State of Delaware, with full power and authority to conduct its business as it is currently being conducted and to own its assets. The Company has full power and authority to consummate the Exchange and to execute, deliver and perform its obligations under this Agreement, the New Notes Indenture and the New Notes.
(b)Delivery Free of Liens. Upon the Company’s delivery of the Exchange Consideration to any Exchanging Investor pursuant to the Exchange, such Exchange Consideration will be free and clear of all Liens created by the Company.
(c)Listing of Common Stock. The Common Stock is listed on The Nasdaq Global Market. To the extent required by the rules and regulations of Nasdaq, at or before the Closing, the Company will have submitted to Nasdaq a Listing of Additional Shares Notification Form with respect to the Exchange Shares and the Conversion Shares (as defined below). The
- 5 -


Company will use its commercially reasonable efforts to maintain the listing of the Exchange Shares and the Conversion Shares on The Nasdaq Global Market for so long as the Common Stock is then so listed. Neither the Company nor any of its subsidiaries is in violation of any of the rules, regulations or requirements of Nasdaq, and, to the knowledge of the Company and its subsidiaries, there are no facts or circumstances that would reasonably lead to delisting or suspension or termination of trading of the Common Stock on The Nasdaq Global Market. The Exchange, and any other transactions contemplated by this Agreement, the New Notes Indenture and the New Securities, including the issuance of the New Securities and any Conversion Shares upon conversion of the New Notes, do not contravene, or require stockholder approval pursuant to, the rules and regulations of Nasdaq.
(d)Securities Act Matters.
(i)Assuming the accuracy of the representations and warranties of the Investor, made on behalf of itself and the Exchanging Investors, the offer, sale and delivery of the New Securities in exchange for the Existing Notes pursuant to this Agreement and the issuance of any Conversion Shares upon conversion of the New Notes in accordance with the New Notes Indenture are exempt from the registration requirements of the Securities Act.
(ii)When issued pursuant to this Agreement, the New Notes will not be of the same class as securities listed on a national securities exchange registered under Section 6 of the Exchange Act, or quoted in a U.S. automated inter-dealer quotation system, within the meaning of Rule 144A(d)(3)(i) under the Securities Act.
(iii)Assuming the accuracy of the representations and warranties of the Investor, made on behalf of itself and the Exchanging Investors, the Exchange Shares, when issued to the Exchanging Investors, will be free of any restrictive legend and will be designated with an unrestricted CUSIP number and will not be subject to restrictions on transfer promulgated under the Securities Act by persons who are not affiliates of the Company and were not affiliates of the Company in the last three months. For purposes of Rule 144 under the Securities Act, the Company acknowledges and agrees that in accordance with Rule 144(d)(3)(ii) the holding period of the Existing Notes may be tacked onto the holding period of the Exchange Shares. The Company is not, and never has been, a “shell company” (as defined in Rule 12b-2 under the Exchange Act) and is not an issuer of a type identified in, or subject to, Rule 144(i)(1) under the Securities Act.
(iv)Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf has, directly or indirectly, offered, sold or solicited any offer to buy any security at any time or in any manner that would be integrated with the offer, sale and delivery of the New Securities and any Conversion Shares for purposes of the Securities Act or the rules and regulations of Nasdaq.
(v)Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf has, directly or indirectly, engaged in any form of general solicitation or general advertising within the meaning of Rule 502 under the Securities Act or otherwise through a “public offering” within the meaning of Section 4(a)(2) of the Securities Act, in each case, in respect of the transactions contemplated in this Agreement.
(vi)The Company has not, and, to the knowledge of the Company, none of its respective officers, directors or affiliates or anyone acting on any such person’s behalf has, (1) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of the Common Stock or any other security of the Company to facilitate the sale or resale of any of the New Securities or any Conversion Shares, or (2) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the New Securities or any Conversion Shares.
- 6 -


(e)Enforceability of New Notes. Each New Note to be issued pursuant to this Agreement has been duly authorized by the Company and, when issued, authenticated and delivered in the manner provided for in the New Notes Indenture and this Agreement, will be validly issued, will constitute a valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or similar laws affecting creditors’ rights generally or by equitable principles relating to enforceability, including principles of commercial reasonableness, good faith and fair dealing, regardless of whether enforcement is sought in a proceeding at law or in equity, and will be entitled to the benefits of the New Notes Indenture.
(f)Enforceability of New Notes Indenture. The New Notes Indenture has been duly authorized by the Company and the Subsidiary Guarantors and, when executed and delivered by the Company and the Subsidiary Guarantors, and duly authorized, executed and delivered by the New Notes Trustee, will constitute a valid and binding obligation of the Company and the Subsidiary Guarantors, enforceable against the Company and the Subsidiary Guarantors, as applicable, in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or similar laws affecting creditors’ rights generally or by equitable principles relating to enforceability, including principles of commercial reasonableness, good faith and fair dealing, regardless of whether enforcement is sought in a proceeding at law or in equity.
(g)Exchange Shares; Conversion Shares.
(i)The Exchange Shares have been duly authorized and, when issued pursuant to this Agreement, will be validly issued, fully paid and non-assessable and free from all taxes (other than taxes, if any, arising if the Exchange Shares are issued in the name of any Person other than the applicable Exchanging Investor) and Liens with respect to the issue thereof, with the holders thereof being entitled to all rights accorded to a holder of Common Stock, and the issuance of any such Exchange Shares will not be subject to any preemptive or similar rights.
(ii)Subject to the terms of the New Notes Indenture, the New Notes will be convertible into shares of Common Stock (together, if applicable, with cash in lieu of any fractional share of Common Stock). The Company has duly authorized and reserved a number of shares of Common Stock for issuance upon conversion of the New Notes equal to the initial maximum number of such shares issuable upon conversion (assuming for this purpose the maximum increase to the “Conversion Rate” in connection with any “Make-Whole Fundamental Change” (each, as defined in the New Notes Indenture)) (the “Conversion Shares”), and, when such Conversion Shares are issued upon conversion of the New Notes in accordance with the terms of the New Notes and the New Notes Indenture, such Conversion Shares will be duly authorized, validly issued, fully paid and non-assessable and free from all taxes (other than taxes, if any, arising if the Conversion Shares are issued in the name of any Person other than the applicable Exchanging Investor) and Liens with respect to the issue thereof, with the holders thereof being entitled to all rights accorded to a holder of Common Stock, and the issuance of any such Conversion Shares will not be subject to any preemptive or similar rights.
(iii)The execution, delivery and performance by the Company of this Agreement, the New Notes Indenture and the New Notes, the execution, delivery and performance by the Subsidiary Guarantors of the New Notes Indenture, and the consummation of the transactions contemplated by this Agreement, the New Notes Indenture and the New Notes, will not: (1) obligate the Company or any Subsidiary Guarantor to offer to issue, or issue, shares of Common Stock or other securities to any person or entity (other than the Investor and the Exchanging Investors) (other than Conversion Shares issuable upon conversion of the New Notes); or (2) result in a right of
- 7 -


any holder of the Company’s securities to adjust the exercise, conversion, exchange or reset price under, and will not result in any other anti-dilution or other adjustments (automatic or otherwise) under, any securities of the Company (other than according to the terms of the New Notes).
(h)Trust Indenture Act. Assuming the accuracy of the representations and warranties of the Investor, made on behalf of itself and the Exchanging Investors, it is not necessary to qualify the New Notes Indenture under the Trust Indenture Act of 1939, as amended, in connection with the Exchange.
(i)Non-Contravention. The execution and delivery by the Company and the Subsidiary Guarantors, as applicable, of, and the performance by the Company and the Subsidiary Guarantors of their respective obligations under, this Agreement, the New Notes Indenture and the New Notes, as applicable, and the consummation of the transactions contemplated by this Agreement, the New Notes Indenture and the New Notes, will not (i) contravene any law, rule or regulation binding on the Company or any of its subsidiaries or any judgment or order of any court or arbitrator or governmental or regulatory authority applicable to the Company or any such subsidiary; (ii) constitute a breach or violation or result in a default under any loan agreement, mortgage, lease or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which any of the foregoing is bound; or (iii) constitute a breach or violation or result in a default under the organizational documents of the Company or any of its subsidiaries, except, in the case of clauses (i) and (ii) above, for such contraventions, conflicts, violations or defaults that would not, individually or in the aggregate, reasonably be expected to result in a material adverse effect on the business, properties, management, financial position, prospects, condition (financial or otherwise), stockholders’ equity or results of operations of the Company and its subsidiaries taken as a whole or on the performance by the Company and the Subsidiary Guarantors of their respective obligations under this Agreement, the New Notes Indenture and the New Notes (any such material adverse effect, a “Material Adverse Effect”).
(j)No Consents. No consent, approval, authorization, order, license, registration or qualification of or with any court or governmental or regulatory authority is required for the execution and delivery by the Company and the Subsidiary Guarantors, as applicable, of, and the performance by the Company and the Subsidiary Guarantors of their respective obligations under, this Agreement, the New Notes Indenture and the New Notes, as applicable, and the consummation of the transactions contemplated by this Agreement, the New Notes Indenture and the New Notes, except such as have been obtained or made (or will, at the Closing, have been obtained or made) and any filings as may be required under the Exchange Act.
(k)Authorization, Execution and Delivery of This Agreement. This Agreement has been duly authorized, executed and delivered by the Company.
(l)Investment Company Act. Neither the Company nor any Subsidiary Guarantor is and, after giving effect to the transactions contemplated by this Agreement, will be required to register as, an “investment company” within the meaning of the Investment Company Act of 1940, as amended, and the rules and regulations of the SEC thereunder.
(m)Accuracy of General Disclosure Package. The General Disclosure Package, taken as a whole, does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. As of their respective dates, the consolidated financial statements of the Company and its subsidiaries included in the General Disclosure Package complied as to form in all material respects with applicable accounting requirements and the published rules and regulations of the SEC (including Regulation S-X) with respect thereto. Such financial statements have been prepared in accordance with the U.S. Generally Accepted Accounting Principles (subject, in the case of unaudited quarterly financial statements, to normal year-end adjustments and absence of certain footnote disclosures), and fairly present in all material respects the consolidated financial position of the Company and its subsidiaries as of the
- 8 -


dates thereof and the consolidated results of their operations, cash flows and changes in stockholders equity for the periods specified.
(n)Bring-Down of Representations and Warranties. Unless the Company notifies the Investor in writing to the contrary at or before the Closing, each representation and warranty of the Company contained in this Agreement will be deemed to have been reaffirmed and confirmed as of the Closing.
(o)No Defaults. No default or event of default under the Existing Notes or the Existing Indenture will exist immediately following the execution of this Agreement or on the Closing Date or will result from the consummation of the transactions contemplated by this Agreement.
(p)Solvency. On each of the date hereof and immediately after giving effect to the Exchange on the Closing Date, the Company has not taken action, and no action has been taken by a third party, for the winding up, dissolution or liquidation or similar executory or judicial proceeding in respect of the Company, or for the appointment of a liquidator, custodian, receiver, trustee, administrator or other similar officer for the Company or all of its assets or revenues.
(q)Litigation. Except as described in the General Disclosure Package (but excluding any cautionary or predictive disclosures that do not expressly relate to specific prior occurrences at the Company or a subsidiary of the Company set forth under the headings “Risk Factors” or disclosure of risks set forth in any “forward-looking statements” disclaimer, or disclosures in any other statements that are similarly cautionary or predictive in nature), no proceeding is pending before or, to the knowledge of the Company, threatened by, any governmental or regulatory authority to which the Company is a party, (i) that purports to affect or pertain to this Agreement, the New Notes Indenture, the New Notes, the Exchange or any other transactions contemplated hereby or thereby or (ii) that has as the subject thereof any assets owned by the Company or any of its subsidiaries, in each case, that would, if adversely determined, reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. No injunction, writ, temporary restraining order or any order of any nature has been issued by any court or other governmental or regulatory authority purporting to enjoin or restrain the execution, delivery or performance of this Agreement, the New Notes Indenture or the New Notes, or directing that the Exchange or any other transactions provided for herein or therein not be consummated as herein or therein provided.
(r)[Reserved].
(s)Brokers’ Fees. No broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission in connection with the consummation of the transactions contemplated by this Agreement based upon arrangements made by or on behalf of the Company or its affiliates.
(t)Mutual Negotiation. The Company acknowledges that the terms of the transactions contemplated by this Agreement have been mutually negotiated among the parties hereto. The Company was given a meaningful opportunity to negotiate the terms of the transactions contemplated by this Agreement.
(u)Additional Documentation. The Company will, upon request, execute and deliver any additional documents that the Investor, any Exchanging Investor, the Existing Notes Trustee or the New Notes Trustee may reasonably request to complete the Exchange and consummate the transactions contemplated by this Agreement, the New Notes Indenture and the New Notes.
(v)Financing Arrangements. The Company shall use reasonable best efforts to maintain in effect and consummate the financings contemplated by the Commitment Letter (as defined below) by no later than December 4, 2026 (the “Financing Deadline”).
Section 5.REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE INVESTOR AND THE EXCHANGING INVESTORS. The Investor, for itself and on behalf of each Exchanging Investor, represents and warrants, as of the date hereof and as of the Closing Date, to the Company and covenants with the Company that:
(a)Due Formation, Valid Existence and Good Standing; Authorization, Execution and Delivery of This Agreement. The Investor, for itself and on behalf of each Exchanging
- 9 -


Investor, (i) is duly formed, validly existing and in good standing under the laws of the jurisdiction of its organization with full power and authority to exchange, sell, assign and transfer the Existing Notes to be exchanged pursuant to, and to enter into, this Agreement and perform all obligations required to be performed by the Investor, on behalf of each Exchanging Investor under this Agreement; and (ii) has duly authorized, executed and delivered this Agreement.
(b)Power to Perform Obligations and Bind Accounts; Survival of Authority. If the Investor is exchanging any Existing Notes or acquiring any of the Exchange Consideration as a fiduciary or agent for one or more accounts (including any Accounts that are Exchanging Investors), then the Investor represents that it has (i) the requisite investment discretion with respect to each such account necessary to effect the Exchange; (ii) full power to make the representations, warranties and covenants set forth in this Section 5 on behalf of such account; and (iii) contractual authority with respect to each such account. All authority conferred in this Agreement will survive the dissolution of the Investor, and any representation, warranty, undertaking and obligation of the Investor under this Agreement will be binding upon the trustees in bankruptcy, legal representatives, successors and assigns of the Investor. Annex I hereto is a true, correct and complete list of (i) the name of each Account and (ii) the principal amount of such Account’s Existing Notes.
(c)Ownership of Existing Notes. Each of the Exchanging Investors is and, immediately before the Closing, will be the beneficial owner of (or otherwise will have sole discretionary management authority with respect to) the Existing Notes set forth next to its name on Annex I.
(d)Rule 144 Matters. Neither the Investor nor any other Exchanging Investor is, as of the date of this Agreement, or, at the Closing, will be, and, at no time during the three months preceding the date of this Agreement or preceding the Closing, was or will any of them be, a “person” (as such term is defined in Rule 144 under the Securities Act, a “Person”) that is an “affiliate” (as such term is defined in Rule 144 under the Securities Act, an “Affiliate”) of the Company. To the Investor’s knowledge, no Exchanging Investor acquired any of the Existing Notes, directly or indirectly, from any Person that is an Affiliate of the Company.
(e)Passage of Good Title; No Liens. When the Existing Notes are exchanged pursuant to this Agreement, the Company will acquire good, marketable and unencumbered title to the Existing Notes, free and clear of all Liens.
(f)Non-Contravention. The Exchange and the other transactions contemplated hereby to be performed by the Investor or any Exchanging Investor will not (i) contravene any law, rule or regulation binding on the Investor or such Exchanging Investor or any investment guideline or restriction applicable to the Investor or such Exchanging Investor; (ii) constitute a breach or violation or result in a default under the organizational documents (or any similar documents governing each Account) of the Investor or such Exchanging Investor; or (iii) constitute a breach or violation or result in a default under any loan agreement, mortgage, lease or other agreement or instrument to which the Investor or such Exchanging Investor is a party or by which it is bound, except, in the case of clauses (i) and (iii) above, for such contraventions, conflicts, violations or defaults that would not, individually or in the aggregate, reasonably be expected to result in a material adverse effect on the performance by the Investor or such Exchanging Investor of their respective obligations under this Agreement.
(g)Jurisdiction of Residence. The Investor and each Exchanging Investor is a resident of the jurisdiction set forth on Exhibit A attached to this Agreement.
(h)Compliance with Certain Laws; No Consents. The Investor and each Exchanging Investor will comply with all applicable laws and regulations in effect in any jurisdiction in which the Investor or any of the Exchanging Investors acquires any New Securities pursuant to the Exchange and will obtain any consent, approval or permission required for any such acquisition under the laws and regulations of any jurisdiction to which the Investor or any of the Exchanging Investors is subject or in which the Investor or any Exchanging Investor acquires any New Securities pursuant to the Exchange.
(i)Acknowledgment of Risks; Investment Sophistication. The Investor and each Exchanging Investor understands and accepts that the New Securities to be acquired in the
- 10 -


Exchange involve risks. Each of the Investor and the Exchanging Investors has such knowledge, skill and experience in business, financial and investment matters that such person is capable of evaluating the merits and risks of the Exchange and an investment in the New Securities. With the assistance of each Exchanging Investor’s own professional advisors, to the extent that the Exchanging Investor has deemed appropriate, each Exchanging Investor has made its own legal, tax, accounting and financial evaluation of the merits and risks of an investment in the New Securities and the consequences of the Exchange and this Agreement. Each Exchanging Investor has considered the suitability of the New Securities as an investment in light of its own circumstances and financial condition, and has determined that such investment is consistent with its financial needs, objectives and condition and each of the Investor and the Exchanging Investor is able to bear the risks associated with an investment in the New Securities. The Investor and each Exchanging Investor understands that it should consult with its own tax advisors in order to determine the U.S. federal, state, and local and non-U.S. tax consequences of the Exchange as well as the ownership, disposition or conversion of the New Securities and any Conversion Shares in light of the Investor's and each Exchanging Investor’s particular circumstances.
(j)No View to Distribution; No Registration. Each Exchanging Investor is acquiring the New Securities solely for such Exchanging Investor’s own beneficial account, for investment purposes, and not with a view to, or for resale in connection with, any distribution of the New Securities in violation of the Securities Act; provided, however, that by making the representations herein, the Investor does not agree to hold any of the New Securities for any minimum or other specific term and reserves the right to assign, transfer or otherwise dispose of any of the New Securities at any time pursuant to an effective registration statement under, or an exemption from the registration requirements of, the Securities Act. Each of the Investor and the Exchanging Investors understands that the offer and sale of the New Securities have not been registered under the Securities Act or any state securities laws by reason of specific exemptions under the provisions thereof that depend in part upon the investment intent of the Investor and the Exchanging Investors and the accuracy of the other representations made by the Investor, for itself and on behalf of each Exchanging Investor, in this Agreement. As a result, the New Notes, and if converted to Conversion Shares, the Conversion Shares, may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act as described in the Indenture (including, but not limited to, Section 2 thereof), and the Investor, for itself and on behalf of each Account, hereby agrees that neither it nor any Account will sell the New Notes nor the Conversion Shares other than in compliance with such transfer restrictions. Further, the Investor and each Account acknowledges that the New Notes and if converted to the Conversion Shares, the Conversion Shares will carry a restrictive legend and will be designated with a restricted CUSIP number until such time as the restrictive legend can be removed. Each of the Investor and the Exchanging Investors understands that the Company and its affiliates and agents are relying upon the representations and agreements contained in this Agreement (and any supplemental information) for the purpose of determining whether the Exchange meets the requirements for such exemptions.
(k)Information Provided. The Investor and each Exchanging Investor acknowledges that no person has been authorized to give any information or to make any representation concerning the Company or the Exchange other than as contained in this Agreement and the General Disclosure Package. The Company takes no responsibility for, and provides no assurance as to the reliability of, any other information that others may provide to the Investor or any Exchanging Investor.
(l)No Recommendation. The Investor confirms that each of the Investor and the Exchanging Investors is not relying on any statement (written or oral), representation or warranty made by, or on behalf of, the Company or any of its affiliates or agents as investment, tax or other advice or as a recommendation to participate in the Exchange and receive the Exchange Consideration in exchange for Existing Notes. The Investor confirms that each of the Investor and the Exchanging Investors has had access to and the opportunity to read the New Notes
- 11 -


Indenture and has not relied on any statement (written or oral) of the Company or any of its affiliates or agents as to the terms of the New Securities other than as set forth in the General Disclosure Package, this Agreement, the New Notes Indenture and the New Securities. Neither the Company, nor any of its affiliates or agents is acting or has acted as an advisor to the Investor or any Exchanging Investor in deciding whether to participate in the Exchange and to exchange Existing Notes for the Exchange Consideration.
(m)Investment Decision Matters. Except as set forth in this Agreement, the Investor confirms that none of the Company or any of its affiliates or agents have (i) given any guarantee or representation as to the potential success, return, effect or benefit (either legal, regulatory, tax, financial, accounting or otherwise) of an investment in the New Securities; or (ii) made any representation to the Investor or any Exchanging Investor regarding the legality of an investment in the New Securities under applicable investment guidelines, laws or regulations. In deciding to participate in the Exchange, each of the Investor and the Exchanging Investors is not relying on the advice or recommendations of the Company, or its affiliates or agents, and has made its own independent decision that the terms of the Exchange and the investment in the New Securities are suitable and appropriate for it.
(n)Due Diligence. Each of the Investor and the Exchanging Investors is familiar with the business and financial condition and operations of the Company and has had the opportunity to conduct its own investigation of the Company and the New Securities. The Investor, on behalf of itself and each Exchanging Investor, has had access to and the opportunity to review the General Disclosure Package and such other information concerning the Company and the New Securities it deems necessary to enable it to make an informed investment decision concerning the Exchange. The Investor, on behalf of itself and each Exchanging Investor, has been offered the opportunity to ask questions of the Company and received answers thereto, as it deems necessary to enable it to make an informed investment decision concerning the Exchange.
(o)No Regulatory Agency Recommendation or Approval. Each of the Investor and the Exchanging Investors understands that no federal or state agency has passed upon the merits or risks of an investment in the New Securities or made any recommendation or endorsement, or made any finding or determination concerning the fairness or advisability, of such investment or the consequences of the Exchange and this Agreement.
(p)Institutional Accredited Investor and Qualified Institutional Buyer Status. Each Exchanging Investor is (i) an institutional “accredited investor” within the meaning of Rule 501(a)(1), (2), (3), (7), (8), (9), (12) or (13) of Regulation D under the Securities Act; or (ii) a “qualified institutional buyer” as defined in Rule 144A under the Securities Act. Each of the Investor and the Exchanging Investors agrees to furnish any additional information reasonably requested by the Company or any of its affiliates or agents to assure compliance with applicable U.S. federal and state securities laws in connection with the Exchange.
(q)Mutual Negotiation. The Investor acknowledges that the terms of the Exchange have been mutually negotiated between the Investor (for itself and on behalf of each Exchanging Investor) and the Company. The Investor was given a meaningful opportunity to negotiate the terms of the Exchange on behalf of itself and each Exchanging Investor. The Investor had a sufficient amount of time to consider whether to participate in the Exchange, and neither the Company nor any of its affiliates or agents, has placed any pressure on the Investor to respond to the opportunity to participate in the Exchange.
(r)[Reserved].
(s)Additional Documentation. The Investor will, upon request, execute and deliver, for itself and on behalf of any Exchanging Investor, any additional documents that the Company, the Existing Notes Trustee or the New Notes Trustee may reasonably request to complete the Exchange.
(t)Bring-Down of Representations and Warranties. Except to the extent that the Investor notifies the Company in writing to the contrary at or before the Closing, each of the Investor’s representations and warranties, on behalf of itself and each Exchanging Investor, contained in this Agreement will be deemed to have been reaffirmed and confirmed as of the Closing.
- 12 -


(u)Wall-Cross Matters. The Investor acknowledges and agrees that each of the Investor and the Exchanging Investors has not transacted, and will not transact, in any securities of the Company, including, but not limited to, any hedging transactions, from the time the Investor was first contacted by the Company with respect to the transactions contemplated by this Agreement until after the Release Time (as defined below). Solely for purposes of this Section 5(u), subject to the Investor’s compliance with its obligations under U.S. federal securities laws and the Investor’s internal policies, (i) “Investor” will not include any employees or affiliates of the Investor that are effectively walled off by appropriate “Fire Wall” information barriers approved by the Investor’s legal or compliance department; and (ii) the foregoing representations and covenants of this Section 5(u) will not apply to any transaction by or on behalf of an Account that was effected without the advice or participation of, or such Account’s receipt of information regarding the transactions contemplated hereby provided by, the Investor.
(v)[Reserved].
(w)No Public Market. The Investor acknowledges and agrees on behalf of itself and each Exchanging Investor that no public market exists for the New Notes and that there is no assurance that a public market will ever develop for the New Notes.
Section 6.CONDITIONS TO OBLIGATIONS OF THE PARTIES.
(a)Conditions to the Company’s Obligations. The obligation of the Company to deliver the Exchange Consideration is subject to the satisfaction at or prior to the Closing of each of the following conditions precedent:
(i)the representations and warranties of the Investor, for itself and on behalf of the Exchanging Investors, in Section 5 hereof are true and correct as of the Closing in all respects with the same effect as though such representations and warranties had been made as of the Closing;
(ii)all covenants of the Investor, for itself and on behalf of the Exchanging Investors, in Section 5 to be performed at or before the Closing have been performed; and
(iii)the receipt by the Company of a valid DWAC Withdrawal and, if applicable, DWAC Deposits, in each case conforming to the requirements set forth in this Agreement.
(b)Conditions to the Investor’s Obligations. The obligation of the Investor, on behalf of the Exchanging Investors, to deliver (or cause to be delivered) the Existing Notes is subject to the satisfaction at or prior to the Closing of each of the following conditions precedent:
(i)the representations and warranties of the Company in Section 4 are true and correct as of the Closing in all respects with the same effect as though such representations and warranties had been made as of the Closing;
(ii)all covenants of the Company in this Agreement to be performed at or before the Closing have been performed;
(iii)the Company and the Subsidiary Guarantors shall execute and deliver to the New Notes Trustee and the Investor the New Notes Indenture and the Company shall execute and deliver to the New Notes Trustee the New Notes;
(iv)the Company shall have paid all fees and expenses due on the Closing Date to the Investor and their representatives, including all amounts owed to Paul Hastings LLP, as counsel to the Investor invoiced at least two Business Days prior to the Closing Date;
(v)the New Notes Indenture shall have been duly executed and delivered by the New Notes Trustee, the New Notes shall have been duly authenticated by the New Notes Trustee, the New Notes shall be eligible for delivery through DTC and the
- 13 -


Exchange Shares shall be eligible for delivery through DTC bearing unrestricted CUSIP numbers and without any restrictive legend;
(vi)as of the Closing Date, (A) there shall not have occurred any suspension or limitation of trading in the Common Stock on The Nasdaq Global Market, or any delisting or notice of delisting with respect to the Common Stock (other than any notice for failure to satisfy the minimum bid requirement set forth in Nasdaq Rule 5550(a)(2)), and (B) the Company shall not have received any objections from Nasdaq regarding the Company’s Listing of Additional Shares Notification Form (if required) in respect of the Exchange Shares and the Conversion Shares;
(vii)the Investor shall have received an a draft of that certain commitment letter provided by Blue Torch Capital LP (the “Commitment Letter”) , in form and substance satisfactory to the Investor, providing for funding, together with the other financings contemplated thereunder, sufficient, after fees, expenses and other required payments, to repay all outstanding New Notes and related interest and other amounts in full in cash at their stated maturity; and
(viii)such additional documents, information and certifications as the Investor may reasonably request to complete the Exchange and consummate the transactions contemplated by this Agreement (including, without limitation, a customary secretary’s certificate and evidence of good standing of the Company).
Section 7.THE RELEASE TIME. As of the date of this Agreement, the Company is not aware of, and has not provided to the Investor or any Exchanging Investor, any material non-public information regarding the Company or its securities, other than any material non-public information relating to the Exchange, the Commitment Letter and the Draft Earnings Release. The Company agrees, at or before 8:30 a.m., New York City time, on November 23, 2026 (such time and date, the “Release Time”), to publicly disclose (i) the exchange of the Existing Notes contemplated by this Agreement and similar exchange agreements in a press release or a Current Report on Form 8-K and (ii) any other material non-public information (including the Commitment Letter and the Draft Earnings Release) regarding the Company or its securities provided to the Investor or any Exchanging Investor as of or prior to the date hereof. The Company acknowledges and agrees that, following the Release Time, none of the information provided by or on behalf of the Company to the Investor and the Exchanging Investors in connection with the Exchange will constitute material non-public information. The Company understands and acknowledges that the Investor and the Exchanging Investors and persons acting on their behalf will rely on the representations, warranties, covenants, provisions and agreements set forth in this Section 7 in effecting transactions in the securities of the Company and of other persons. Without the prior written consent of the Investor, the Company shall not disclose the name of the Investor or any Exchanging Investor in any public filing or announcement, unless such disclosure is required by applicable law, rule, regulation or legal process (in which case the Company shall, to the extent permitted by law, provide the Investor with notice of such disclosure a reasonable period of time in advance of such disclosure so that the Investor may seek protective measures, if desired).
Section 8.TAX MATTERS.
(a)Withholding. The Investor acknowledges that, to the extent the applicable payment recipient has not provided the required tax forms and made the applicable certifications described in Section 8(b), the Company and its agents shall be entitled to deduct and withhold from any amounts payable or deliverable pursuant to this Agreement such amounts as are required (as determined in good faith by the applicable withholding agent) to be deducted or withheld under applicable law. To the extent any amounts are timely withheld and remitted to the appropriate taxing authority (including, for the avoidance of doubt, due to the failure or inability of an Investor (or Account(s) of such Investor, if applicable) to comply with the obligations set
- 14 -


forth in Section 8(b)), such amounts shall be treated for all purposes of this Agreement as having been paid or delivered to the Investor (or Account(s) of such Investor, if applicable) to whom such amounts otherwise would have been paid or delivered. The Investor (or Account(s) of such Investor, if applicable) further acknowledges that any Investor (or Account(s) of such Investor, if applicable) may be subject to U.S. federal withholding or U.S. federal backup withholding (currently at rates of 30% and 24%, respectively) on certain payments or deliveries made to such Investor (or Account(s) of such Investor, if applicable) unless such Exchanging Investor properly establishes an exemption from, or a reduced rate of, such withholding or backup withholding.
(b)Required Tax Forms and Certifications. The Investor (or Account(s) of such Investor, if applicable) shall deliver to the Company, at least one (1) Business Day prior to the Closing, an accurately completed and duly executed IRS Form W-9 or IRS Form W-8BEN, W-8BEN-E, W-8ECI, W-8IMY, or other applicable IRS Form W-8, as applicable (or any successor form), together with any required attachments. The Investor (or Account(s) of such Investor, if applicable) acknowledges that, if the Investor (or Account(s) of such Investor, if applicable): (i) is a “United States person” (as defined in Section 7701(a) of the Code) then the Company must be provided with an accurately completed and duly executed IRS Form W-9 certifying that such Investor or Account is exempt from backup withholding, or (ii) is not a “United States person” (as defined in Section 7701(a) of the Code) (a “Non-U.S. Holder”), then the Company must be provided with an accurately completed and duly executed IRS Form W-8BEN, W-8BEN-E, W-8ECI, W-8IMY, or other applicable IRS Form W-8, as applicable (or any successor form), together with any required attachments, establishing an exemption from or a reduction in U.S. federal withholding. Without limiting the generality of the foregoing, the Investor (or Account(s) of such Investor, if applicable) hereby represents that it is able to receive any amounts payable or deliverable hereunder (including any amounts attributable to accrued and unpaid interest) without any U.S. federal withholding tax and is entitled to provide U.S. tax forms and required attachments indicating the same and, if such U.S. tax forms and attachments do not otherwise establish a 0% U.S. withholding tax rate on such amounts, hereby certifies that the Investor (or Account(s) of such Investor, if applicable) fulfills the requirements of the “portfolio interest exemption” as indicated in Exhibit C, and agrees to hold the Company and its agents harmless for the breach of such representation and certification. Any forms required to be delivered to the Company pursuant to this Section 8(b) shall be delivered in accordance with Section 9(h); provided that such communication shall be made via electronic mail.
(c)Tax Treatment. The Company and the Exchanging Investors intend that, for U.S. federal income tax purposes, the exchange of the Existing Notes for the New Notes and Exchange Shares pursuant to this Agreement constitutes a tax-free recapitalization within the meaning of Section 368(a)(1)(E) of the Code (the “Intended Tax Treatment”). The Company and the Exchanging Investors shall file all tax returns consistent with, and shall not take any action inconsistent with, the Intended Tax Treatment, unless otherwise required by applicable law.
Section 9.MISCELLANEOUS.
(a)Waiver; Amendment. Neither this Agreement nor any provisions hereof may be modified, changed, discharged or terminated except by an instrument in writing, signed by the party against whom any waiver, change, discharge or termination is sought.
(b)Assignability. Neither this Agreement nor any right, remedy, obligation or liability arising hereunder or by reason hereof will be assignable by the Company, on the one hand, or the Investor or any Exchanging Investor, on the other hand, without the prior written consent of the other party; provided that the Investor and any Exchanging Investor may assign this Agreement and any of its rights hereunder, in whole or in part, without the consent of the Company, to any affiliate of, or to any Person or account managed, sponsored, advised or administered by, such Investor or Exchanging Investor or any entity or affiliate of any entity that manages, sponsors, advises or administers such Investor or Exchanging Investor.
(c)Further Instruments and Acts. Each of the parties to this Agreement agrees to execute and deliver such further instruments and do such further acts as may be reasonably necessary or proper to more effectively carry out the purposes of this Agreement.
- 15 -


(d)Waiver of Jury Trial. EACH OF THE COMPANY, THE INVESTOR AND THE EXCHANGING INVESTORS IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY WITH RESPECT TO ANY LEGAL PROCEEDING ARISING OUT OF THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT.
(e)Governing Law. This Agreement will be governed by and construed in accordance with the internal laws of the State of New York.
(f)Section and Other Headings. The section and other headings contained in this Agreement are for reference purposes only and will not affect the meaning or interpretation of this Agreement.
(g)Counterparts. This Agreement may be executed in any number of counterparts, each of which when so executed and delivered will be deemed to be an original and all of which together will be deemed to be one and the same agreement. Delivery of an executed signature page to this Agreement by facsimile or other electronic transmission (including pdf format) will be effective as delivery of a manually executed counterpart hereof.
(h)Notices. All notices and other communications provided for herein will be in writing and will be deemed to have been duly given if delivered personally or sent by nationally recognized overnight courier service or by registered or certified mail, return receipt requested, postage prepaid to the following addresses (or such other address as either party may have hereafter specified by notice in writing to the other): (i) if to the Company, Veritone, Inc., 5291 California Ave, Ste. 350, Irvine, CA 92617, Attention: Craig Gatarz, Chief Legal Officer, Email: [*]; and (ii) if to the Investor or any Exchanging Investor, the address provided on Exhibit A hereto with respect to the Investor.
(i)Binding Effect. The provisions of this Agreement will be binding upon and accrue to the benefit of the parties hereto and the Exchanging Investors and their respective heirs, legal representatives, successors and permitted assigns.
(j)Notification of Changes. The Investor covenants and agrees to notify the Company upon the occurrence of any event prior to the Closing that would cause any representation, warranty, or covenant of the Investor, made on behalf of itself and each Exchanging Investor, contained in this Agreement to be false or incorrect.
(k)Severability. If any term or provision of this Agreement is invalid, illegal or unenforceable in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other term or provision of this Agreement or invalidate or render unenforceable such term or provision in any other jurisdiction.
(l)Entire Agreement. This Agreement, including all Annexes and Exhibits hereto, constitutes the entire agreement of the parties hereto with respect to the specific subject matter covered hereby, and supersedes in their entirety all other agreements or understandings between or among the parties with respect to such specific subject matter.
(m)[Reserved].
(n)Termination. In the event that the transactions contemplated by this Agreement shall not have occurred with respect to the Investor on or before November 16, 2026 due to the Company’s or the Investor’s failure to satisfy any of the conditions required to be satisfied by it in Section 6 (and the nonbreaching party’s failure to waive such unsatisfied condition(s)), the nonbreaching party shall have the option to terminate this Agreement with respect to such breaching party at the close of business on such date.
(o)Expenses. The Company shall, at the Closing (or, if this Agreement is terminated prior to the Closing for any reason other than the Investor or any Exchanging Investor’s breach, within five (5) Business Days following such termination), reimburse the Investor for all reasonable, out of pocket costs and expenses incurred by it (or any Account) in connection with the structuring, documentation, negotiation and closing of the transactions contemplated by this Agreement (including, without limitation, as applicable, all reasonable legal fees of outside counsel). The Company’s obligations under this Section 9(o) shall survive any termination of this Agreement.
(p)Payment for Consent. Notwithstanding anything to the contrary set forth in the New Notes Indenture or the New Notes , for so long as the Investor (or any Account) is a
- 16 -


beneficial owner of New Notes, the Company shall not, directly or indirectly, pay or cause to be paid any consideration, whether by way of interest, fee or otherwise, to any holder or beneficial owner of New Notes for or as an inducement to any consent, waiver, amendment, modification or supplement of any of the terms or provisions of the New Notes Indenture or the New Notes unless such consideration is bona fide offered to be paid to the Investor (or Account) on a pro rata basis to the extent the Investor (or Account) so consents, waives or agrees to amend, modify or supplement such term(s) or provision(s) of the New Notes Indenture or the New Notes (such pro rata payment offer, the “Pro Rata Offer”) (calculated based on the amount of New Notes beneficially owned by the Investor (or Account) that so consents, waives, agrees to amend, modify or supplement) and to the extent such consideration is actually so paid; provided, that, (i) the Investor (or Account) shall be given not less than five Business Days’ notice (or such shorter time as agreed by such Investor (or Account)) of the deadline to consent, waive or agree to such amendment, modification or supplement in such Pro Rata Offer (the “Pro Rata Offer Notice”) and (ii) such Pro Rata Offer Notice may be provided to some or all beneficial owners any time prior to the execution of, or within 60 days following the execution of, any such related consent, waiver, amendment, modification or supplement of any of the New Notes Indenture or the New Notes. The rights of the Investor (and any Account) set forth in this Section 9(p) (the “Consent Fee Right”) may be assigned or transferred to an affiliate of, or to any Person or account managed, sponsored, advised or administered by, such Investor (or Account) or any entity or affiliate of any entity that manages, sponsors, advises or administers such Investor (or Account) and may not otherwise be sold, assigned, transferred, given away or in any other manner transferred or disposed of, in whole or in part, to anyone. Any such sale, assignment, transfer, gift or disposal of the Consent Fee Right not permitted by this Section 9(p) shall be null and void. The Consent Fee Right shall terminate if at any time the Investor (or Account) is no longer the beneficial owner of any New Notes.
(q)Survival. The representations and warranties made herein shall survive the Closing until the expiration of the applicable statute of limitations. All covenants and agreements contained herein shall survive the Closing until, by their respective terms, they are no longer operative.
[The Remainder of This Page Intentionally Left Blank; Signature Pages Follow]
- 17 -


IN WITNESS WHEREOF, the parties to this Agreement have caused this Agreement to be duly executed as of the date first written above.
Investor (in its capacities described in the first paragraph hereof):
Legal Name
By        
Name:
Title:
[Signature Page to Exchange Agreement]


Veritone, Inc.
By:        
Name:
Title:

[Signature Page to Exchange Agreement]

ANNEX I

Exchange Consideration
Name of
Exchanging Investor (i.e., Beneficial Owner)
Aggregate Principal Amount of Existing Notes to Be Exchanged by Exchanging Investor
Aggregate Principal Amount of New Notes to Be Issued to Exchanging Investor in Exchange
Number of Exchange Shares to Be Issued to Exchanging Investor in Exchange
Amount of Accrued Interest Payment to Be Paid to Exchanging Investor in Exchange
$
$
$
Total:
$
$
$




EXHIBIT A
Exchanging Investor Information
(Complete the Following Form for Each Exchanging Investor)



Legal Name of Exchanging Investor:            


Exchanging Investor’s Address:            
            
            

Telephone:            

Country (and, if applicable, State)
of Residence:            

Taxpayer Identification Number:            

    Account for Existing Notes    Account for New Securities
DTC Participant Number:        DTC Participant Number:
                    
DTC Participant Name:        DTC Participant Name:
                    
DTC Participant Phone Number:        DTC Participant Phone Number:
                    
DTC Participant Contact Email:        DTC Participant Contact Email:
                    
        Account # at DTC Participant:
                    
Wire Instructions for Accrued Interest Payment:
ABA Routing #:
Intermediary Bank Name:
Beneficiary Bank:
Account Number:
FFC Account Number:
FFC Account Name:
Contact Email:
A-1

EXHIBIT B
Exchange Procedures
NOTICE TO INVESTOR
Attached are Investor Exchange Procedures for the settlement of the exchange (the “Exchange”) of 1.75% Convertible Senior Notes due 2026, CUSIP 92347MAB6 (the “Existing Notes”) of Veritone, Inc. (the “Company”) for (i) the Company’s 1.75% Convertible Senior Notes due December 15, 2026 (the “New Notes”), (ii) cash in an amount equal to the accrued and unpaid interest on the Existing Notes from, and including, May 15, 2026 to, but excluding, November 15, 2026 (as defined in the Exchange Agreement (as defined below)) (the “Accrued Interest Payment”) and (iii) a number of shares of the Company’s common stock, $0.001 par value per share (the “Common Stock”), equal to the number of shares of Common Stock set forth on Annex I (the “Exchange Shares” and, together with the Accrued Interest Payment and the New Notes, the “Exchange Consideration”), pursuant to the Exchange Agreement, dated as of November 12, 2026, between you and the Company, which is expected to occur on November 13, 2026. To ensure timely settlement, please follow the instructions for the Exchange as set forth on the following page.
Your failure to comply with the attached instructions may delay your receipt of the Exchange Consideration.

B-1


Delivery of the Existing Notes
You must direct the eligible DTC participant through which you hold a beneficial interest in the Existing Notes to post on November 13, 2026, no later than 9:30 a.m., New York City time, withdrawal instructions through DTC via DWAC for the aggregate principal amount of Existing Notes (CUSIP #92347MAB6) set forth in column 2 of Annex I of the Exchange Agreement to be exchanged. It is important that this instruction be submitted and the DWAC posted on November 13, 2026; if it is posted before November 13, 2026, then it will expire unaccepted and will need to be re-posted on November13, 2026.
To Receive the New Securities
You must direct your eligible DTC participant through which you wish to hold a beneficial interest in the New Securities to post on November 13, 2026, no later than 9:30 a.m., New York City time, deposit instructions through DTC via DWAC for (i) the aggregate principal amount of New Notes set forth in column 3 of Annex I of the Exchange Agreement and (ii) the aggregate number of the Exchange Shares set forth in column 4 of Annex I of the Exchange Agreement. It is important that these instructions be submitted and the DWAC posted on November 13, 2026; if it is posted before November 13, 2026, then they will expire unaccepted and will need to be re-posted on November 13, 2026.
To Receive the Accrued Interest Payment
You must provide valid wire instructions to the Company to receive the Accrued Interest Payment set forth in column 5 of Annex I of the Exchange Agreement.
Closing
On November 13, 2026, after the Company receives your Existing Notes and your delivery instructions as set forth above, and subject to the satisfaction of the conditions to Closing as set forth in your Exchange Agreement, the Company will deliver the New Securities and the Accrued Interest Payment in accordance with the delivery instructions above.

B-2

EXHIBIT C
Tax Matters
U.S. Federal Backup Withholding Tax
Under U.S. federal income tax law, an Exchanging Investor who exchanges Existing Notes for the Exchange Consideration generally must provide such Exchanging Investor’s correct taxpayer identification number (“TIN”) on IRS Form W-9 (attached hereto) or otherwise establish a basis for exemption from backup withholding. A TIN generally is an individual’s social security number or an entity’s employer identification number. If the correct TIN is not provided, the Exchanging Investor may be subject to penalties imposed by the IRS, and certain payments made to them may be subject to U.S. backup withholding tax (currently set at 24% of the payment). If an Investor (or Account(s) of such Investor, if applicable) is required to provide a TIN but does not have a TIN, the Exchanging Investor should consult its tax advisor regarding how to obtain a TIN. Certain holders are not subject to these backup withholding and reporting requirements. A Non-U.S. Holder may be required to comply with certain certification procedures to establish that the holder is not a “United States person” (as defined in Section 7701(a) of the Code) in order to avoid backup withholding. U.S. backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules generally will be allowed as a refund or credit against the applicable Exchanging Investor’s U.S. federal income tax liability, provided that the required information is timely furnished to the IRS. In certain circumstances, information returns may be filed with the IRS. Copies of these information returns may also be made available under the provisions of a specific treaty or agreement to the tax authorities of the country in which a Non-U.S. Holder resides. Exchanging Investors are urged to consult their tax advisors regarding how to complete the appropriate forms and to determine whether they are exempt from backup withholding or other withholding taxes.

Portfolio Interest Exemption (for certain Exchanging Investors That Are Non-U.S. Holders)

Under U.S. federal income tax law, an Investor (or Account(s) of such Investor, if applicable) that is otherwise not eligible to provide an IRS Form W-9 may be subject to U.S. federal withholding tax on payments or deliveries attributable to accrued and unpaid interest unless such Investor or Account establishes an exemption. To the extent required by Section 8(b) of the Agreement, each Investor (or Account(s) of such Investor, if applicable) hereby claims such an exemption under the so-called “portfolio interest exemption” and represents and certifies as set forth in Paragraph C below (in addition to providing the applicable IRS Form W-8). However, if the Investor (or Account(s) of such Investor, if applicable) is an intermediary, a foreign partnership or other flow-through entity, then the adjustments in Paragraphs A and B will be made to the statements below:

A.    The following certification is made as applied to the Investor (or Account(s) of such Investor, if applicable):

    record ownership under Clause 1 of Paragraph C below.

C-1


B.    The following certifications are made as applied to the partners/members that are beneficial owners of the Existing Notes claiming the portfolio interest exemption:

    beneficial ownership under Clause 1 of Paragraph C below,
    the status in Clause 3 of Paragraph C below, and
    the status in Clause 4 of Paragraph C below.

C.    The following certification is made as applied to the Investor (or Account(s) of such Investor, if applicable) as well as the partners/members that are beneficial owners of the Existing Notes claiming the portfolio interest exemption:

1.    It is the sole record and beneficial owner of the Existing Notes in respect of which it is providing this certification.
2.    It is not a “bank” (within the meaning of Section 881(c)(3)(A) of the Code).
3.    It is not a “10-percent shareholder” of the Company (within the meaning of Section 881(c)(3)(B) or Section 871(h)(3)(B) of the Code).
4.    It is not a “controlled foreign corporation” (as such term is described in Section 881(c)(3)(C) of the Code) related to the Company (within the meaning of Section 864(d)(4) of the Code).
C-2



EXHIBIT D

Form of New Notes Indenture
D-1